Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.730

-1.4%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Keiko who wrote (7517)	12/17/1997 12:25:00 PM
From: Steve Stuart	Read Replies (1) of 14328

Selfcare investment/lawsuit: Many things have changed since the post that you linked to. However it is still true that Trinity can make money on the deal even as SLF shares are sinking. Just not as much. TRIBY paid $2.5 million for SLF shares, some of which are the subject of a lawsuit. Taking Ronan at his word from the last conference call: If Trinity ends up owning at least 80% of the disputed shares, then their cost basis will be about $3.80 per SLF share. Another way to think about it: each share of TRIBY owns roughly 0.034 shares of SLF. Assume that this is factored into the price already. Thus when SLF drops by $1, the value of a TRIBY share should drop by about 3 cents. -Steve Stuart

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next